Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Noevir Holdings Co., Ltd. (4928:JPX), powered by AI.
Noevir Holdings Co., Ltd. is currently trading at ¥4,275. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Noevir Holdings Co., Ltd. on Alpha Lenz.
Noevir Holdings Co., Ltd.'s P/E ratio is 18.2.
“Noevir Holdings Co., Ltd. trades at a P/E of 18.2 (fair value) with solid ROE of 15.0%.”
Ask for details →Noevir Holdings Co., Ltd. is a prominent enterprise within the cosmetics and personal care industry, headquartered in Japan. The company's primary function revolves around the development, production, and marketing of a wide array of beauty and skincare products. Noevir's portfolio includes high-quality facial care, body care, hair care, makeup, and nutritional supplements, catering to both domestic and international markets. Renowned for its commitment to research and innovation, Noevir often integrates natural ingredients with cutting-edge technology to ensure efficacy and safety in its products. Within the financial market, Noevir Holdings plays a significant role due to its robust brand reputation and extensive distribution networks, which include direct sales and retail partnerships. The company has carved out a niche by appealing to consumers seeking premium, environmentally conscious beauty solutions. Noevir's influence extends across a variety of sectors, impacting retail, e-commerce, and wellness industries. As a publicly traded entity, it offers investors exposure to the dynamic and resilient cosmetics industry, which continues to thrive amid global beauty trends and growing consumer awareness towards personal care.
“Noevir Holdings Co., Ltd. trades at a P/E of 18.2 (fair value) with solid ROE of 15.0%.”
Ask for details →Noevir Holdings Co., Ltd. (ticker: 4928) is a company listed on JPX in the Consumer Defensive sector (Household & Personal Products). It has approximately 1,369 employees. Market cap is $146.0B.
The current price is 4,275 with a P/E ratio of 18.18x and P/B of 2.72x.
ROE is 14.98% and operating margin is 17.12%. Annual revenue is $64.7B.